Elsevier

Journal of Infection

Volume 86, Issue 6, June 2023, Pages 622-625
Journal of Infection

Letter to the Editor
Molnupiravir and nirmatrelvir–ritonavir reduce mortality risk during post-acute COVID-19 phase

https://doi.org/10.1016/j.jinf.2023.02.029Get rights and content

Cited by (0)

Eric Yuk Fai Wan, Boyuan Wang, and Sukriti Mathur are co-first authors and contributed equally.

View Abstract